The Latest Breaking News from ETF

Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain

Healthcare ETFs are quietly feasting on the gains from Wall Street’s latest obsession – the $150 billion obesity-drug boom. As Eli Lilly And Co (NYSE:LLY), Novo Nordisk A/S (NYSE:NVO), and Pfizer Inc (NYSE:PFE) jostle for dominance in the fast-growing GLP-1 market, investors pile into ETFs that offer diversified and far…

Benzinga · Oct 30, 2025

4 Stocks To Buy As Precious Metals Soar

The massive rally in gold hit its first significant pullback in months last week, dipping under $4,000 per troy ounce after touching as high as $4,350.

Benzinga · Oct 30, 2025

Top 6 ETFs To Watch As Wall Street's Strongest Six Months Begin

Right now ahead of Halloween, the real suspense might be in ETF investing strategies. With markets seesawing between hopes for rate cuts and the resilience of earnings, investors are dusting off one of Wall Street’s spooky old sayings:  Sell in May and go away.

Benzinga · Oct 30, 2025

Direxion's BRKU, BRKD ETFs Allow Speculators To Trade Warren Buffett's Berkshire Hathaway Conglomerate

While the much-covered bull market may appear to be losing steam, one steady voice has helped investors navigate the turmoil of price discovery: Warren Buffett. Known as the Oracle of Omaha, Buffett has been at the helm of Berkshire Hathaway Inc (NYSE:BRK) (NYSE:BRK) for several decades, translating to a magnitude…

Benzinga · Oct 29, 2025

Fed Rate Cuts Help Bolster The Case For The ProShares Nasdaq-100 High Income ETF

Ever since the challenges of the COVID-19 pandemic, a key headwind that has stymied multiple administrations is inflation. Sure, the economy has been able to bounce back from the worst of the crisis, but the response wasn't free of consequence. Like a calculated gambit in chess, policymakers essentially sacrificed materiel…

Benzinga · Oct 29, 2025

Exclusive: Bitcoin ETFs, Treasury Firms 'Double-Edged Sword,' Says Trezor CEO — They Bring Money, But Not Owning 'A Piece' Of BTC Is A 'Pity'

Matej Zak, CEO of hardware wallet company Trezor, called the rise of Bitcoin (CRYPTO: BTC) exchange-traded funds and corporate treasuries a "double-edged sword" as they bring in fresh money to the market but also weaken some of BTC's core ideals.

Benzinga · Oct 29, 2025

Bitcoin, XRP Stay Range-Bound As Ethereum, Dogecoin Slip 2% Ahead Of Fed Meeting

Bitcoin is steady around the $114,000 level, supported by optimism over new ETF launches, increased whale activity, and growing institutional accumulation.

Benzinga · Oct 28, 2025

Solana's First US Staking ETF Could Be 'Huge', Bitwise's Matt Hougan Says

Solana's (CRYPTO: SOL) first-ever U.S. staking ETF has launched to overwhelming demand, despite a government shutdown and a consolidating crypto market.

Benzinga · Oct 28, 2025

Debunking Three Myths About Defined Outcome ETFs (aka Buffered ETFs)

Defined outcome ETFs offer a middle ground between traditional equity and fixed-income investments, helping provide downside protection and upside participation.

Kiplinger · Oct 28, 2025

HBAR Token Rallies 8% Ahead Of Nasdaq ETF Debut — Anthony Scaramucci Describes It As The 'Sound Of Inevitability'

Hedera (CRYPTO: HBAR) is trading higher late Monday ahead of the launch of its spot exchange-traded fund on Wall Street.

Benzinga · Oct 28, 2025